scholarly journals Using the Consumer Experience with Pharmacy Services Survey as a quality metric for ambulatory care pharmacies: older adults' perspectives

BMJ Open ◽  
2016 ◽  
Vol 6 (5) ◽  
pp. e011241 ◽  
Author(s):  
Olayinka O Shiyanbola ◽  
David A Mott ◽  
Kenneth D Croes
2014 ◽  
Vol 48 (5) ◽  
pp. 817-826 ◽  
Author(s):  
Aline Pinto Marques ◽  
Dalia Elena Romero Montilla ◽  
Wanessa da Silva de Almeida ◽  
Carla Lourenço Tavares de Andrade

OBJECTIVE To analyze the temporal evolution of the hospitalization of older adults due to ambulatory care sensitive conditions according to their structure, magnitude and causes. METHODS Cross-sectional study based on data from the Hospital Information System of the Brazilian Unified Health System and from the Primary Care Information System, referring to people aged 60 to 74 years living in the state of Rio de Janeiro, Souhteastern Brazil. The proportion and rate of hospitalizations due to ambulatory care sensitive conditions were calculated, both the global rate and, according to diagnoses, the most prevalent ones. The coverage of the Family Health Strategy and the number of medical consultations attended by older adults in primary care were estimated. To analyze the indicators’ impact on hospitalizations, a linear correlation test was used. RESULTS We found an intense reduction in hospitalizations due to ambulatory care sensitive conditions for all causes and age groups. Heart failure, cerebrovascular diseases and chronic obstructive pulmonary diseases concentrated 50.0% of the hospitalizations. Adults older than 69 years had a higher risk of hospitalization due to one of these causes. We observed a higher risk of hospitalization among men. A negative correlation was found between the hospitalizations and the indicators of access to primary care. CONCLUSIONS Primary healthcare in the state of Rio de Janeiro has been significantly impacting the hospital morbidity of the older population. Studies of hospitalizations due to ambulatory care sensitive conditions can aid the identification of the main causes that are sensitive to the intervention of the health services, in order to indicate which actions are more effective to reduce hospitalizations and to increase the population’s quality of life.


PLoS ONE ◽  
2018 ◽  
Vol 13 (12) ◽  
pp. e0208888 ◽  
Author(s):  
Yelena Petrosyan ◽  
Jan M. Barnsley ◽  
Kerry Kuluski ◽  
Barbara Liu ◽  
Walter P. Wodchis

2014 ◽  
Vol 62 (8) ◽  
pp. 1442-1450 ◽  
Author(s):  
Lillian Min ◽  
David Reuben ◽  
Arun Karlamangla ◽  
Arash Naeim ◽  
Katherine Prenovost ◽  
...  

2016 ◽  
Vol 33 (1) ◽  
pp. 8-14 ◽  
Author(s):  
Amber Lanae Smith ◽  
Valerie Palmer ◽  
Nada Farhat ◽  
James S. Kalus ◽  
Krishna Thavarajah ◽  
...  

Background: No systematic evaluations of a comprehensive clinical pharmacy process measures currently exist to determine an optimal ambulatory care collaboration model for chronic obstructive pulmonary disease (COPD) patients. Objective: Describe the impact of a pharmacist-provided clinical COPD bundle on the management of COPD in a hospital-based ambulatory care clinic. Methods: This retrospective cohort analysis evaluated patients with COPD managed in an outpatient pulmonary clinic. The primary objective of this study was to assess the completion of 4 metrics known to improve the management of COPD: (1) medication therapy management, (2) quality measures including smoking cessation and vaccines, (3) patient adherence, and (4) patient education. The secondary objective was to evaluate the impact of the clinical COPD bundle on clinical and economic outcomes at 30 and 90 days post–initial visit. Results: A total of 138 patients were included in the study; 70 patients served as controls and 68 patients received the COPD bundle from the clinical pharmacist. No patients from the control group had all 4 metrics completed as documented, compared to 66 of the COPD bundle group ( P < .0001). Additionally, a statistically significant difference was found in all 4 metrics when evaluated individually. Clinical pharmacy services reduced the number of phone call consults at 90 days ( P = .04) but did not have a statistically significant impact on any additional pre-identified clinical outcomes. Conclusion: A pharmacist-driven clinical COPD bundle was associated with significant increases in the completion and documentation of 4 metrics known to improve the outpatient management of COPD.


1997 ◽  
Vol 10 (1) ◽  
pp. 52-67
Author(s):  
Kimberly Olson

The purpose of this article is to describe the integration of clinical pharmacy services into an already exist ing HIV clinic. Ambulatory care pharmacy services were the only discipline not represented in the hospi tal based HIV clinic. With the move toward ambulatory care, the introduction of the new class of HIV drugs called the protease inhibitors, and the strong physician support of inpatient pharmacy services, the tim ing for pharmacy integration into the clinic was optimal. This article describes our goals for the clinic, the need for justification of pharmacy services through documentation, and the preparation steps made which established permanent pharmacy services in the HIV clinic. Daily procedures, interventions, statis tics of the pharmacy service, and barriers to success are also described. Patient information materials and examples of the documentation forms used by the clinic pharmacists are provided. This article is meant to aid other pharmacists who wish to integrate pharmacy services into an ambulatory HIV clinic setting.


1992 ◽  
Vol 5 (1) ◽  
pp. 7-11
Author(s):  
Douglas F. Covey ◽  
Diane D. Shackelford ◽  
Wallace E. Geck

Roles for pharmacists are evolving rapidly in the ambulatory care setting. This is primarily due to increasing inpatient costs with a resultant shifting of costs to the outpatient section. This shift has subsequently presented larger numbers of patients and sicker patients to the outpatient setting. This article describes the involvement of a clinical pharmacist in a multidisciplinary hypertension clinic. Detailed are the procedures used to evaluate a patient from consult to discharge, and the responsibilities of the clinical pharmacist, the clinic physician, and the nurse practitioner are reviewed. Finally, methods of documentation and quality assurance are outlined.


Sign in / Sign up

Export Citation Format

Share Document